CareFirst, Ryse Health partner to take on uncontrolled Type 2 diabetes
By Frank DiamondAug 14, 2023
CareFirst BlueCross BlueShield is joining forces with Ryse Health, a company that specializes in providing in-person and virtual care for patients with uncontrolled Type 2 diabetes, in hopes of driving better long-term outcomes.
CareFirst officials said they believe the effort will help improve care by better pinpointing what they need most.
A Patient-Centered Approach to Type2 Diabetes Care
Aug 8, 2023 | 1501 Health
Chronic disease, cardiometabolic health in particular, is a massive problem in the United States—significantly impacting many lives in a negative way, leading to millions of deaths every year and costing nearly a trillion dollars.
It's clear there's an approach that could deliver better outcomes than the status quo of care, and Ryse Health, based in Maryland and DC and led by Richard Gurley, is providing it.
Exclusive: Ryse Health draws $6.5M Series A for hybrid diabetes care
Erin Brodwin , author of Axios Pro: Health Tech Deals
Diabetes Care provider Ryse Health drew $6.5 million in Series A funds for its virtual and in-person services, CEO Richard Gurley tells Axios exclusively.
Diabetes Care provider Ryse Health drew $6.5 million in Series A funds for its virtual and in-person services, CEO Richard Gurley tells Axios exclusively.
Why I Co-Founded Ryse Health
Published May 24, 2022
When I was leaving WelbeHealth, I was intent on being thoughtful about my next full-time role. I told my wife, “I don’t know if I’ll end up at a 4-person company or a 40,000-person company, but the one thing I know I won’t do is start my own company.” And yet, here I am: co-founder of Ryse Health, a new startup helping patients manage type 2 diabetes and other chronic diseases. The obvious question that springs from that epic flip flop is “Why?”
Ryse Health just raised $3.4M. Here’s who they’re looking to hire next
Apr 11, 2022 4:10pm
Cofounder and Chief Medical Officer Dr. Erin Kane says that the Baltimore- and DMV-rooted startup wants to expand its clinical and technological capacity as it grows into new markets.